Written by MarketBeatUpdated September 4, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, United Therapeutics, Pfizer, Ionis Pharmaceuticals, and Merck & Co. are identified as key pharmaceutical stocks to watch based on their high trading volume and potential growth opportunities. Investors are attracted to pharmaceutical stocks for their potential revenue growth while also facing risks from clinical trial results and regulatory challenges. These companies are involved in the development of medications in various therapeutic areas, including treatments for diabetes, pulmonary arterial hypertension, and COVID-19. MarketBeat previews the top five stocks to own by October 1st. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersJoby Aviation's Pullback: A Gift for Investors Who See the FutureBy Jeffrey Neal Johnson | September 2, 2025“Sell Nvidia before earnings”From InvestorPlace (Ad)Tesla (NASDAQ:TSLA) Director Sells $42,034,800.00 in StockBy MarketBeat | September 1, 2025Free Cash Flow Boom Keeps Microsoft Ahead of the PackBy Chris Markoch | August 29, 2025Defense Dividends: 3 Strong Performers That Are Raising PayoutsBy Leo Miller | August 29, 2025Strange crypto pattern discovered by 40-person research teamFrom Crypto Swap Profits (Ad)Ollie’s Bargain Outlet: Buy it While It’s Still a BargainBy Thomas Hughes | August 29, 2025Top 5 September Stock Picks: Market Tailwinds Drive New MomentumBy Thomas Hughes | September 1, 2025 Recent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatUpdated September 4, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, United Therapeutics, Pfizer, Ionis Pharmaceuticals, and Merck & Co. are identified as key pharmaceutical stocks to watch based on their high trading volume and potential growth opportunities. Investors are attracted to pharmaceutical stocks for their potential revenue growth while also facing risks from clinical trial results and regulatory challenges. These companies are involved in the development of medications in various therapeutic areas, including treatments for diabetes, pulmonary arterial hypertension, and COVID-19. MarketBeat previews the top five stocks to own by October 1st. Like this article? Share it with a colleague. Link copied to clipboard.
